Aprea Therapeutics will join Guggenheim's 3rd Annual Healthcare Innovation Conference to talk about its cancer treatment plans.

APRE · Aprea Therapeutics, Inc.

The AI's read

The conference gives investors a chance to hear about Aprea's cancer-drug programs. The announcement reports no new trial findings or program changes, so it adds no new evidence about the company's business outlook.